Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age‐related macular degeneration
Acta Ophthalmologica · 2025
DOI: 10.1111/aos.16759 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Scott Lenhof und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Macula Lutea, Retina, Tomography, Optical Coherence, Visual Acuity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Purpose
To assess subretinal fibrosis (SF) occurrence in neovascular age‐related macular degeneration (nAMD), according to macular neovascularisation (MNV) subtypes.
Methods
A Retrospective national multi centre cohort study included eyes with naive nAMD. Main outcome measures were, according to MNV subtypes, cumulative incidence for SF, risk factors, and best corrected visual acuity (BCVA) for 36 months.
Results
Four hundred and twenty eyes were included. Cumulative incidence of SF was 34.3% at 1 year, 39.0% at 2 years and 50.6% at 3 years. In multivariable analysis, Type 2 and mixed type 1 and 2 MNV were associated ( p < 0.001) with a more frequent and rapid development of SF (respectively 85.5% and 81.0% at 1 year, then 95.8% and 93.1% at 3 years) than Types 1 and 3 (respectively 11.3% and 3.6% at 1 year, then 22.9% and 12.7% at 3 years). In Type 2 and mixed type 1 and 2 MNV combined, at baseline a worse BCVA ( p = 0.02) and a higher maximal subretinal hyperreflective material (SHRM) thickness ( p = 0.005) were associated with SF development at 3 years. In Type 1 MNV, the presence at baseline of intraretinal fluid (IRF) ( p = 0.007) or SHRM ( p < 0.001) and a higher percentage of visits with IRF ( p < 0.001) or with SHRM ( p < 0.001) were associated with SF occurrence. For Type 3 MNV, only a higher percentage of visits with SHRM ( p = 0.001) was associated with SF. Including all MNV subtypes, eyes with a worse BCVA at baseline were associated with SF development ( p < 0.001). Conversely, presence of SF at 3 years was associated with a worse baseline BCVA ( p < 0.001).
Conclusion
Occurrence of SF differs when considering apart MNV subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Department, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France.
- MATEIS Laboratory, UMR-CNRS 5510, INSA, University of Claude Bernard Lyon 1, Villeurbanne, France.
- University of Claude Bernard Lyon 1, Lyon, France.
- Ophthalmology Department, Aix-Marseille University, Hôpital Nord, Marseille, France.
- Timone Neuroscience Institute, Aix-Marseille University, Marseille, France.
- LEO Eye Center, Hôpital Privé de l'Est Lyonnais, Saint-Priest, France.
ORCID-Profile: Pierre Gascon, Benjamin Wolff, Thibaud Mathis
Zitieren
APA
Lenhof, S., Kodjikian, L., Gascon, P., Gadiollet, E., Feldman, A., De Bats, F., Wolff, B., Pradat, P., & Mathis, T. (2025). Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age‐related macular degeneration. Acta Ophthalmologica. https://doi.org/10.1111/aos.16759
Vancouver
Lenhof S, Kodjikian L, Gascon P, Gadiollet E, Feldman A, De Bats F, et al. Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age‐related macular degeneration. Acta Ophthalmologica. 2025. doi:10.1111/aos.16759
BibTeX
@article{Lenhof2025,
author = {Lenhof, Scott and Kodjikian, Laurent and Gascon, Pierre and Gadiollet, Etienne and Feldman, Audrey and De Bats, Flore and Wolff, Benjamin and Pradat, Pierre and Mathis, Thibaud},
title = {Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age‐related macular degeneration},
journal = {Acta Ophthalmologica},
year = {2025},
doi = {10.1111/aos.16759}
}
EUVIMED